Sunday, March 19, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Smiths Detection Awarded Another 9.5M for JCADs

by Global Biodefense Staff
February 2, 2015

The Army Contracting Command, Aberdeen Proving Ground, Md., has awarded a $9.5 million contract modification to Smiths Detection this week for M41A Joint Chemical Agent Detectors (JCADs) and supportive equipment items.

JCAD is a hand-held device that automatically detects, identifies, and alerts operators to the presence of nerve and blister vapors, as well as one blood chemical agent vapor and one toxic industrial chemical vapor.

Operators use JCAD to determine the presence of chemical warfare agent and toxic industrial chemical vapors by:

  • Checking personnel for contamination
  • Monitoring in and around a stationary vehicle or shelter’s interior and exterior
  • Monitoring aircraft while on the ground

The order includes 1,687 each of the JCADS, along with six Platform Interface Kits and 116 Sieve Packs. The estimated completion date of the contract is Sept. 30, 2016.

Source: Defense.gov

Tags: AwardsChemical Detection

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC